Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.07.2021 | Case report

Antineoplastics

Pneumonitis: 21 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Matsubara T, et al. Clinical course and prognosis of patients with lung cancer who develop anticancer therapy-related pneumonitis. Journal of Cancer Research and Clinical Oncology 147: 1857-1864, No. 6, Jun 2021. Available from: URL: http://doi.org/10.1007/s00432-020-03478-2 Matsubara T, et al. Clinical course and prognosis of patients with lung cancer who develop anticancer therapy-related pneumonitis. Journal of Cancer Research and Clinical Oncology 147: 1857-1864, No. 6, Jun 2021. Available from: URL: http://​doi.​org/​10.​1007/​s00432-020-03478-2
Metadaten
Titel
Antineoplastics
Pneumonitis: 21 case reports
Publikationsdatum
01.07.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-98977-2

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Tozinameran

Case report

Multiple drugs